TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis

Rationale: Enhancing non–CFTR (cystic fibrosis transmembrane conductance regulator)-mediated anion secretion is an attractive therapeutic approach for the treatment of cystic fibrosis (CF) and other mucoobstructive diseases. Objectives: To determine the effects of TMEM16A potentiation on epithelial...

Descripción completa

Detalles Bibliográficos
Autores principales: Danahay, Henry L., Lilley, Sarah, Fox, Roy, Charlton, Holly, Sabater, Juan, Button, Brian, McCarthy, Clive, Collingwood, Stephen P., Gosling, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159426/
https://www.ncbi.nlm.nih.gov/pubmed/31898911
http://dx.doi.org/10.1164/rccm.201908-1641OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159426/
https://www.ncbi.nlm.nih.gov/pubmed/31898911
http://dx.doi.org/10.1164/rccm.201908-1641OC

Ejemplares similares